Camp4 Therapeutics Corp — Form SCHEDULE 13D/A
Filed August 19, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 24/100
What the filing says
Polaris Management Co. VII, L.L.C. filed an amended Schedule 13D/A regarding beneficial ownership in Camp4 Therapeutics Corp. The filing document itself does not contain the specific share count, percentage ownership, or details of what changed from the prior filing—only the filing header and metadata are visible. Without access to the complete amendment text, concrete ownership figures cannot be stated.
Why this rating
Amendment of a disclosure form is routine SEC compliance. No material transaction, stake change, or operational impact disclosed in metadata alone. Below-threshold event.
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.